Eton Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products utilizing the FDA's 505(b)(2) regulatory pathway. The company's product candidates focuses on liquid formulation, including injectables, oral liquids, and ophthalmics. The company's formula products include: EM-100, an ophthalmic solution indicated for the treatment of allergic conjunctivitis; ET-202, an injectable product candidate to be used in the hospital setting; ET-103, an oral liquid formulation of levothyroxine for the treatment of hypothyroidism; and ET-203, an injectable product candidate to be used in the hospital setting.

Winmark is a franchisor of retail store concepts that buy, sell, and trade used merchandise. Each of the company's retail store brands provide used merchandise at savings from the price of new merchandise. The company's concepts also provide some new merchandise to customers. The company has two reportable business segments, franchising and leasing. The franchising segment franchises retail store concepts that buy, sell, trade and consign merchandise as well as provides consulting services related to franchising. The leasing segment includes Winmark Capital Corporation, its middle-market equipment leasing business and Wirth Business Credit, Inc., its small-ticket financing business.